-
MnTBAP Chloride: Redox Research Workflows
2026-09-02
MnTBAP Chloride gives researchers a mechanistic way to test whether mitochondrial superoxide contributes to oxidative injury, inflammation, or stress-related phenotypes. This workflow-focused guide connects cell protection assays with brain mitochondrial and behavioral studies while emphasizing controls, formulation, and interpretation limits.
-
3-Deazaadenosine Hydrochloride: Assay Logic
2026-09-01
3-Deazaadenosine hydrochloride is a selective S-adenosylhomocysteine hydrolase inhibitor for probing methylation-dependent biology. This guide focuses on causal assay design, interpretation of m6A-related findings, and controls that distinguish pathway-wide effects from the IGF2BP1-TUBB4B-FAK mechanism.
-
How Chiem et al. Found Monkeypox Inhibitors
2026-09-01
Chiem et al. used reporter vaccinia virus assays to screen repurposed antiviral compounds and then confirmed a subset against monkeypox virus, identifying cross-orthopoxvirus activity among 11 candidates. The study provides a practical phenotypic screening framework while emphasizing that in vitro inhibition must be separated from mechanism, selectivity, and clinical efficacy.
-
LINC00942, MSI2, and Cisplatin Resistance in Gastric Cancer
2026-08-31
The reference study identifies LINC00942 as a chemoresistance-associated lncRNA that stabilizes MSI2 by preventing SCFβ-TrCP-mediated degradation, thereby sustaining m6A-dependent c-Myc mRNA stability. Its integrated molecular and in vivo experiments define a regulatory route linking lncRNA expression, protein turnover, RNA modification, stemness, and cisplatin response in gastric cancer.
-
Gallein for GPCR Signaling Research
2026-08-31
Gallein is a practical G protein βγ subunit inhibitor for dissecting GPCR-linked signaling in cancer, immune, cardiac, and emerging metabolic assays. This guide translates published use cases into controlled workflows while showing how the lactate-GPR81/FARP1 study can inspire, but not replace, direct validation of Gβγ-dependent mechanisms.
-
Biotin-Tyramide for Spatial Senescence Validation
2026-08-30
Biotin-tyramide provides enzyme-mediated signal amplification for testing how PURPL, H3K9me3, and senescence markers are organized in cells and tissues. This guide presents a spatial assay strategy that connects the 2025 PURPL study with practical IHC and ISH decisions.
-
SM-164 and the New Logic of Apoptotic Signaling
2026-08-29
SM-164 illustrates how targeted IAP antagonism can convert apoptotic competence into a measurable, mechanism-led research strategy. When viewed alongside recent evidence that RNA Pol II loss activates active death signaling rather than passive transcriptional collapse, it offers translational researchers a framework for separating pathway engagement from nonspecific cytotoxicity.
-
STING agonist-1: B-Cell and TLS Workflows
2026-08-28
Build controlled STING pathway activation assays that connect innate immune signaling with B-cell activation, IRF4 biology, and tertiary lymphoid structure research. This practical guide covers dosing, orthogonal readouts, assay controls, and troubleshooting for translational cancer immunology workflows.
-
LY2228820: A Practical p38 MAPK Assay Strategy
2026-08-28
LY2228820 is a selective p38 MAP kinase inhibitor for dissecting inflammatory, stress-response, and tumor-associated signaling. This guide connects proximal phospho-MK2 measurements with multiomics-informed assay design while defining practical controls, formulation considerations, and experimental limits.
-
PTEN mRNA Assay Design for Resistance Models
2026-08-27
EZ Cap™ Human PTEN mRNA (ψUTP) supports controlled PTEN restoration in mammalian cancer research. This guide focuses on assay architecture, delivery-aware controls, and interpretation of PI3K/Akt pathway inhibition rather than repeating standard product descriptions.
-
Cytochalasin B for Actin-Dependent Entry Assays
2026-08-27
Cytochalasin B, also known as NSC 107658, provides a reversible way to test whether actin remodeling is required for pathogen entry, motility, division, or transport. This workflow translates findings from Drosophila S2 infection biology into controlled, concentration-responsive assays for cytoskeletal research and early drug discovery.
-
KPT-330 Inhibits Osteoclastogenesis in Osteoarthritis
2026-08-26
A 2026 iScience study shows that KPT-330, also known as Selinexor, protects against osteoarthritis progression in a DMM mouse model by suppressing subchondral bone osteoclastogenesis. The work connects XPO1/CRM1-mediated nuclear export with NF-κB and MAPK signaling, providing a mechanistic basis for studying nuclear export inhibition in bone-cartilage disease.
-
Cy3 Goat Anti-Mouse IgG (H+L) Antibody Workflow
2026-08-26
Translate renalase–PMCA4b findings into practical immunofluorescence, western blot, flow cytometry, and tissue-staining workflows with a sensitive mouse IgG detection antibody. The guide emphasizes signal amplification, assay controls, storage discipline, and troubleshooting for reproducible pathway mapping.
-
Tβ4, Notch/NF-κB, and Angiogenesis in Limb Ischemia
2026-08-25
The reference study shows that thymosin-β4 promotes endothelial activity and angiogenic remodeling in critical limb ischemia through coordinated Notch and NF-κB pathway regulation. Its combination of gain-of-function experiments with DAPT and NF-κB inhibition provides a useful preclinical framework for testing pathway-dependent vascular repair.
-
D-Lin-MC3-DMA for Reliable RNA Assays
2026-08-25
A scenario-based guide to using D-Lin-MC3-DMA (SKU A8791) in RNA-delivery workflows linked to cell viability, proliferation, and cytotoxicity testing. It explains formulation compatibility, N/P optimization, assay controls, data interpretation, and practical vendor-selection criteria using published and product-dossier evidence.